Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2024-10-15 00:00:00 ET · period of report 2024-10-11 · accession 0001873919-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-10-15 | 2024-10-11+ | CADL | Aguilar-Cordova Estuardo | 10% | S - Sale | $6.03 | -40.4K | 919.5K | -4% | -$243.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | CADL | 2024-10-11 | S | D | 15,000 | $6.05 | 944,873 | D | — | — | |
| 2 | Common | CADL | 2024-10-14 | S | D | 15,000 | $6.02 | 929,873 | D | — | — | |
| 3 | Common | CADL | 2024-10-15 | S | D | 10,412 | $6.03 | 919,461 | D | — | — |